Cochlear (Germany) Today
| OC5 Stock | EUR 124.00 23.22 15.77% |
PerformanceWeakest
| Odds Of DistressLow
|
Cochlear is trading at 124.00 as of the 16th of February 2026. This is a 15.77 percent decrease since the beginning of the trading day. The stock's lowest day price was 118.46. Cochlear has less than a 10 % chance of experiencing some financial distress in the next two years of operation, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 18th of November 2025 and ending today, the 16th of February 2026. Click here to learn more.
Business Domain Health Care Equipment & Services | Category Healthcare | Classification Health Care |
Cochlear Limited provides implantable hearing solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. Cochlear Limited was incorporated in 1983 and is headquartered in Sydney, Australia. COCHLEAR LTD operates under Medical Devices classification in Germany and is traded on Frankfurt Stock Exchange. The company has 65.4 M outstanding shares. More on Cochlear Limited
Moving against Cochlear Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Cochlear Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Cochlear's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Cochlear or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary, Cochlear's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Cochlear's managers, analysts, and investors.
Environment Score | Governance Score | Social Score |
| President America | Stuart Sayers | ||||
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, Health Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors) | ||||
| Excise Tax Activities | Animal Testing | ||||
Cochlear's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Cochlear's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Debt LevelsCochlear utilizes debt financing to potentially enhance returns on invested capital. The relationship between total debt and total assets provides valuable insight into Cochlear's leverage profile, showing how much of Cochlear's resources are funded through borrowing.
| |||||
Cochlear Limited (OC5) is traded on Frankfurt Exchange in Germany and employs 5,500 people. Cochlear is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 8.16 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Cochlear's market, we take the total number of its shares issued and multiply it by Cochlear's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Cochlear Limited classifies itself under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 65.4 M outstanding shares.
Cochlear Limited has accumulated about 79.01 M in cash with 376.5 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.37.
Check Cochlear Probability Of Bankruptcy
Ownership AllocationCochlear holds a total of 65.4 Million outstanding shares. Over half of Cochlear's outstanding shares are owned by other corporate entities. These other corporate entities are typically referred to as corporate investors that acquire positions in a given instrument to benefit from reduced trade commissions. Consequently, these institutions are subject to different rules and regulations than regular investors in Cochlear. Please watch out for any change in the institutional holdings of Cochlear Limited as this could mean something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Cochlear Ownership Details
Cochlear Historical Income Statement
Cochlear Stock Against Markets
Cochlear Stock Analysis Notes
About 56.0% of the company shares are owned by institutional investors. The company last dividend was issued on the 19th of March 2026. Cochlear Limited provides implantable hearing solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. Cochlear Limited was incorporated in 1983 and is headquartered in Sydney, Australia. COCHLEAR LTD operates under Medical Devices classification in Germany and is traded on Frankfurt Stock Exchange. It employs 3500 people. To find out more about Cochlear Limited contact MBA BE at 61 2 9428 6555 or learn more at https://www.cochlear.com.Cochlear Limited Investment Alerts
| Cochlear Limited generated a negative expected return over the last 90 days | |
| About 56.0% of the company shares are owned by institutional investors | |
| Latest headline from news.google.com: Commodity, healthcare stocks drag Australian shares lower Cochlear loses tune - marketscreener.com |
Cochlear Market Capitalization
The company currently falls under 'Mid-Cap' category with a current market capitalization of 8.16 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Cochlear's market, we take the total number of its shares issued and multiply it by Cochlear's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Cochlear Profitablity
Cochlear's profitability indicators refer to fundamental financial ratios that showcase Cochlear's ability to generate income relative to its revenue or operating costs. If, let's say, Cochlear is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Cochlear's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Cochlear's profitability requires more research than a typical breakdown of Cochlear's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of 0.15 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.22 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.22. Management Efficiency
Cochlear Limited has return on total asset (ROA) of 0.1128 % which means that it generated a profit of $0.1128 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1815 %, meaning that it generated $0.1815 on every $100 dollars invested by stockholders. Cochlear's management efficiency ratios could be used to measure how well Cochlear manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Cochlear's Non Currrent Assets Other are most likely to increase significantly in the upcoming years. The Cochlear's current Other Current Assets is estimated to increase to about 6.1 M, while Total Assets are projected to decrease to roughly 2.2 B.Leadership effectiveness at Cochlear Limited is a strong indicator of its financial stability. We analyze various metrics to provide insights into the stock's investment viability.
Technical Drivers
As of the 16th of February 2026, Cochlear shows the risk adjusted performance of (0.11), and Mean Deviation of 1.21. In respect to fundamental indicators, the technical analysis model gives you tools to check existing technical drivers of Cochlear, as well as the relationship between them. Please confirm Cochlear Limited variance, treynor ratio, and the relationship between the standard deviation and information ratio to decide if Cochlear Limited is priced correctly, providing market reflects its regular price of 124.0 per share.Cochlear Limited Price Movement Analysis
Transformation |
The output start index for this execution was zero with a total number of output elements of sixty-one. Cochlear Limited Tanh Of Price Series is a hyperbolic price transformation function.
Cochlear Outstanding Bonds
Cochlear issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Cochlear Limited uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Cochlear bonds can be classified according to their maturity, which is the date when Cochlear Limited has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
Cochlear Predictive Daily Indicators
Cochlear intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Cochlear stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 0.0447 | |||
| Daily Balance Of Power | (4.19) | |||
| Rate Of Daily Change | 0.84 | |||
| Day Median Price | 121.23 | |||
| Day Typical Price | 122.15 | |||
| Market Facilitation Index | 5.54 | |||
| Price Action Indicator | (8.84) | |||
| Period Momentum Indicator | (23.22) |
Cochlear Forecast Models
Cochlear's time-series forecasting models are one of many Cochlear's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Cochlear's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.Be your own money manager
Our tools can tell you how much better you can do entering a position in Cochlear without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Anywhere Now
Portfolio AnywhereTrack or share privately all of your investments from the convenience of any device |
| All Next | Launch Module |
Cochlear Corporate Management
Elected by the shareholders, the Cochlear's board of directors comprises two types of representatives: Cochlear inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Cochlear. The board's role is to monitor Cochlear's management team and ensure that shareholders' interests are well served. Cochlear's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Cochlear's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Karen ODriscoll | Chief Officer | Profile | |
| Dean Phizacklea | Senior Marketing | Profile | |
| Jennifer Hornery | Senior Culture | Profile | |
| Richard MBA | Pres EMEA | Profile | |
| Jan Eng | Chief Officer | Profile | |
| Jennifer Stevenson | VP Brand | Profile |
Other Information on Investing in Cochlear Stock
Cochlear financial ratios help investors to determine whether Cochlear Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cochlear with respect to the benefits of owning Cochlear security.